Mortality of Neonatal Respiratory Failure Related to Socioeconomic Factors in Hebei Province of ChinaMa L.a, b · Liu C.b · Wang Y.c · Li S.d · Zhai S.e · Gu X.f · Liu F.g · Yan A.h · Guo W.i · Li Y.j · Xiao M.k · Yin J.l · Li Y.m · Liu X.n · Wang R.o · Kirpalani H.p · Sun B.a · Hebei Neonatal Network Study Group
aDepartment of Pediatrics, Children’s Hospital of Fudan University, Shanghai, Departments of Neonatology, bHebei Provincial Children’s Hospital, Shijiazhuang, cBaoding Women’s and Children’s Hospital, Baoding, dHandan Women’s and Children’s Hospital, Handan, eHandan City Central Hospital, Handan, fChina National Petroleum Corporation Central Hospital, Langfang, gBethune International Peace Hospital, Shijiazhuang, hQinhuangdao Women’s and Children’s Hospital, Qinhuangdao, iXingtai City People’s Hospital, Xingtai, jTangshan Women’s and Children’s Hospital, Tangshan, kCangzhou City Central Hospital, Cangzho, lHebei Provincial General Hospital, Shijiazhuang, mSecond Hospital of Hebei Medical University, Shijiazhuang, nChengde Medical College Hospital, Chengde, and oCangzhou City People’s Hospital, Cangzhou, China; pDepartment of Neonatology, Children’s Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pa., USA; Department of Clinical Epidemiology, McMaster University Health Science Center, Hamilton, Ont., Canada
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Dramatic progress has occurred in neonatal intensive care in tertiary centers in mid-eastern China. We investigated the characteristics of neonatal respiratory failure (NRF) including the incidence, management, outcomes and costs in 14 neonatal intensive care units (NICUs) of Hebei, a province at an intermediate economic level in China. Over a period of 12 consecutive months in 2007–2008, perinatal data were collected prospectively from all NICU admissions (n = 11,100). NRF was defined as severe hypoxemia requiring respiratory support for more than 24 h, and was diagnosed in 1,875 newborns (16.9%). The average birth weight of newborns with NRF was 2,200 g (range 600–5,500 g), with 60.9% <2,500 g, and 2% <1,000 g. The male:female ratio was 2.6:1. The leading diagnosis was respiratory distress syndrome; 58.3% of newborns with respiratory distress syndrome received surfactant. Continuous positive airway pressure was used more than ventilation (73.3 vs. 49.1%,p < 0.001). Overall, the mortality rate until discharge was 31.4% (583/1,859). Most deaths (432, 74.1%) followed a parental decision to withdraw care. NRF mortality varied in association with different gross domestic product levels, family annual income and nurse-to-bed ratios. The median cost of a hospital stay was 10,169 CNY (interquartile range: 6,745–16,386) for NRF survivors. We conclude that, despite the available respiratory support in these emerging NICUs, the mortality of NRF remains. This was associated with prematurity, standard of care but also with socioeconomic factors affecting treatment decisions. Assessment of efficacy of respiratory support for NRF in such emerging neonatal services should account for both standard of care and socioeconomic conditions.
© 2010 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.